To study the interaction of lymphocytes and macrophages in the control of extracellular matrix turnover, we determined the effects ofseveral soluble T cell products on mononuclear phagocyte production of metalloproteinases. Cytokines including IL-2, IL4, IL-6, tumor necrosis factor a (TNFa), GM-CSF, and IFN-gamma were each tested for capacity to modulate macrophage metalloproteinase and tissue inhibitor of metalloproteinases (TIMP) expression. The addition of IL4 to cells cultured under basal conditions caused a dose-dependent suppression in the release of 92-kD type IV collagenase without affecting TIMP production. 92-kD enzyme secretion was inhibited by 50% with 1-2 ng/ ml of IL4 and by 90% with 10 ng/ml of IL4. When cells were first exposed to killed Staphylococcus aureus to induce metalloproteinase production, IL4 potently blocked the stimulated release of both interstitial collagenase and 92-kD type IV collagenase, again without effect upon TIMP. Metabolic labeling experiments and Northern hybridizations demonstrated that IL4 exerted its action at a pretranslational level. Furthermore, IL4 possessed the capacity to inhibit metalloproteinase expression even in the relatively immature peripheral blood monocyte. As reported previously
Introduction
Mononuclear phagocytes are developmentally complex cells that subserve a variety of immunoregulatory, phagocytic, and secretory functions. Macrophages can modulate the turnover of extracellular matrix both directly by producing metalloproteinases and proteinase inhibitors ( 1, 2) and also indirectly by secretion of IL-1 (3) and tumor necrosis factor (TNF)' (4), soluble messengers that potently induce metalloproteinase gene expression by resident tissue fibroblasts. The capacity of macrophages to remodel extracellular matrix can in turn be influenced by other cell types such as the activated T lymphocyte, especially at sites of inflammation. In this regard, we have shown that very low concentrations ( 10-40 U/ml) ofthe lymphokine IFN-gamma abolish interstitial collagenase and stromelysin production by human alveolar macrophages (5), even while this factor serves to upregulate most other macrophage functions including tumoricidal capacity (6, 7) .
The production of metalloproteinases and tissue inhibitor of metalloproteinases (TIMP) by mononuclear phagocytes has been the subject of several recent reports (2, 8, 9) . As such cells undergo differentiation from monocytes into resident tissue macrophages, their proteinase armamentarium shifts from an intracellularly stored group of neutrophil-like serine enzymes into a highly regulatable, but secreted battery of metalloproteinases (2, 8, 10) . Two major secreted macrophage metalloenzymes are 92-kD type IV collagenase and interstitial collagenase ( 1, 2, 1 1 ). Production of the 92-kD enzyme is characterized by (a) secretion at a relatively early stage ofcell differentiation (2); (b) high basal levels of expression ( 11 ) ; and (c) catalytic function that appears to replace the highly related 72-kD type IV collagenase released by fibroblasts ( 1 1, 12) . The 92-kD enzyme can cleave a broad spectrum of extracellular matrix substrates that includes native types IV and V collagens, denatured collagens, fibronectin, and insoluble elastin (13, 14) . This latter specificity may provide a link between the massive proliferation of macrophages and abnormal elastolysis found in smoker's emphysema. Catalytic activity of 92-kD type IV collagenase is controlled by the simultaneously secreted counterregulatory molecule TIMP. The potential physiological importance of macrophage metalloproteinase production is underscored by recent in situ hybridization studies demonstrating high levels of stromelysin mRNA in lipid-laden macrophages of atherosclerotic plaques ( 15) and of interstitial collagenase mRNA in macrophage-like cells of the rheumatoid synovial pannus (16) .
IL-4 is a 20-kD glycoprotein produced by activated T cells that influences many biological functions. Originally isolated based on its capacity to induce proliferation of B cells costimulated with anti-IgM antibodies ( 17) , it is now recognized that IL-4 also modulates B cell antibody isotype expression ( 18) , T cell activation (19) , mast cell proliferation (20), and hematopoiesis (21) . As regards the mononuclear phagocyte, IL-4 can exert profound effects that have either activating or suppressing properties. For example, the lymphokine accelerates monocyte-macrophage cell differentiation in vitro (22) and enhances MHC class II antigen expression (22) while inhibiting secretion ofIL-lI3, TNFa, and IL-6 (23, 24) and also blocking osteoclast formation from progenitor mononuclear phagocytes (25) . Furthermore, considerable evidence has accumulated to suggest that IL-4 antagonizes many of the activities of the cosecreted lymphokine IFN-gamma (26, 27 ). Since we have previously reported the suppressive effects ofIFN-gamma on macrophage metalloproteinase expression (5), we embarked upon the present study to assess the potential ofIL-4 to modulate metalloenzyme production by the human alveolar macrophage. Our results indicate that IL-4 potently inhibits macrophage capacity for interstitial collagenase and 92-kD type IV collagenase release without altering TIMP secretion. Furthermore, IFN-7 potentiates the ability of IL-4 to suppress metalloproteinase biosynthetic capacity whereas it antagonizes the inhibitory effect ofIL-4 on cytokine (IL-l and TNFa) production by the macrophage.
Methods
Reagents. Recombinant human IL-4 (I X 106 U/mg) and human IL-6 (3.3 X 10' U/mg) were kindly provided by Sandoz Ltd. (Basel, Switzerland). Recombinant human IFN-gamma (1.3 X 106 U/mg), IL-2 (3.6 X 106 U/mg), TNFa (5 x 106 U/mg), and GM-CSF (3.4 X 106 U/mg) were obtained from Biogen S.A. (Geneva, Switzerland). Specific monoclonal antiserum to human IL-4 was procured from DNAX Inc. (Palo Alto, CA). Killed Staphylococcus aureus (k.S.aureus) was obtained from a single cultured colony and incubated overnight at 37°C in Mueller-Hinton medium (28) . The bacteria were washed twice with PBS, resuspended in PBS containing 10% NaCl, placed at 85°C for 1 h, washed again twice, and then resuspended in PBS.
k. S.aureus processed in this manner were generously provided by Dr. S. Kantengwa, Allergy Unit, Geneva, Switzerland. BSA, lipopolysaccharide from E. coli (LPS), phenylmethylsufonyl fluoride, EDTA, Triton X-100 and protein-A Sepharose were obtained from Sigma Chemical Co. (St. Louis, MO). RPMI 1640, PBS, FCS, penicillin, streptomycin, and L-glutamine were purchased from GIBCO BRL (Paisley, Scotland).
Cell culture. Human alveolar macrophages were harvested from the uninvolved lung tissue of cigarette-smoking individuals undergoing surgical resection for pulmonary carcinoma (29) . Segments or lobes were lavaged at room temperature with 250-500 ml of sterile 0.9% NaCl using a 50-cc syringe introduced in the major bronchial Macrophages were placed into culture as described above. Cells were treated with medium alone, k.S-aureus, and/or various concentrations of the different cytokines. After 72 h ofincubation at 370C, the conditioned media were collected and stored at -20'C until further analysis.
Immunological assays. Samples of conditioned medium were subjected to ELISAs for interstitial collagenase (30) , 92-kD type IV collagenase (31) , and TIMP (32). Our assays for interstitial collagenase and TIMP have been used extensively and employ specific polyclonal antisera that recognize either free collagenase or TIMP or the species cornplexed to one another with equal avidity (30, 32) . The ELISA for 92-kD type IV collagenase is based upon minor modifications of an assay described recently (31) . It also uses a rabbit anti-human polyclonal antibody that we have developed after immunization with enzyme purified from U937 cells (12) and is sensitive in the nanogram range. This antibody recognizes 92-kD zymogen with equal facility to activated enzyme and does so whether or not TIMP is associated. There is no cross-reactivity by ELISA or Western analysis with any ofthe other known metalloproteinases, including the highly related 72-kD type IV collagenase. FCS contributes no immunologically cross-reactive material.
Metabolic labeling and immunoprecipitation studies. All samples subjected to immunoprecipitation were conditioned in the presence of "5S-methionine for 24 h. To determine the effects of IL-4, the cells were exposed to this agent for 24 h before labeling and then again during the study period. To begin the study period, culture medium was replaced with otherwise identical (except forthe use ofdialyzed 5% FCS)methionine-free medium containing 50 AtCi/ml of 35S-methionine (Amersham Corp., Zurich, Switzerland) and the cells were metabolically labeled for the next 24 h. After collection, the samples of conditioned medium containing the labeled proteins were stored at -70°C until further analysis.
For immunoprecipitation, polyclonal antisera to human interstitial collagenase, 92-kD type IV collagenase, and TIMP were used as reported previously (2, 5) . Processed samples were applied to 12% polyacrylamide slab gels and electrophoresis was performed as described by King and Laemmli (33) . The gels were exposed to Kodak XAR-5 X-Omat film (Eastman Kodak Co., Rochester, NY) at -70°C.
IL-I enzyme immunoassay. IL-la and IL-Ij# were measured by enzyme immunoassay using tandem mAbs as previously described (34) .
TNFa radioimmunoassay. Radioimmunoassay for TNFa (IREMedgenix, Fleurus, Belgium) was performed according to the instructions of the suppliers.
RNA preparation. Total cellular RNA from 15 X 106 stimulated and control human alveolar macrophages was extracted by the guanidine isothiocyanate method and purified by cesium chloride density gradient centrifugation as described previously (35, 36) .
RNA analysis. Total RNA (10 Mg) was denatured with formaldehyde and 3-(4-morpholino) propane sulfonic acid (MOPS), electrophoresed on 1.2% agarose gels and stained for RNA integrity with ethidium bromide (0.5 tig/ml). After transfer to a Biodyne nylon membrane (Pall' Ultrafine Filtration Corp., Glen Cove, NY), filters were baked for 2 h at 80°C before prehybridization for 6 h at 58°C with a mixture containing 50% deionized formamide, 5% 5OX Denhardt's solution, 0.25 M Pipes, 5 M NaCl, 0.5 M EDTA, 10% SDS, and 250 ug/ml salmon sperm DNA. Hybridization was performed at 58°C overnight with a 92-kD type IV collagenase cDNA probe (provided by 
Results
To determine which cytokines released by activated T lymphocytes are capable of regulating macrophage metalloproteinase or TIMP expression, freshly harvested human alveolar macrophages were placed in culture in the presence of IL-2, IL-4, IL-6, IFN-gamma, TNFa, or GM-CSF. After 72 h of incubation, conditioned media were harvested and subjected simultaneously to ELISAs for interstitial collagenase, 92-kD type IV collagenase, and TIMP. Interstitial collagenase was not secreted by basal macrophages and no tested cytokine induced its release. As shown in Table I , 92-kD type IV collagenase and TIMP were constitutively produced by the adherent alveolar macrophages at 380 and 103 ng/ 106 cells, respectively. Interestingly, the addition of IL-4 (2 ng/ml) to culture medium reduced secretion of 92-kD enzyme by > 50%. The presence of IL-6 resulted in a twofold increase in TIMP production along with significant, but inconstant effect upon metalloproteinase levels. These results for IL-6 confirm and extend the observations of Lotz and Guerne (37) , who reported specific stimulation of TIMP production by this cytokine in human fibroblasts. Finally, IFN-gamma suppressed 92-kD enzyme release, consistent with our own previous observations (5) . None of the other agents induced changes in metalloproteinase or TIMP biosynthesis that could not be explained by parallel alterations in levels of total new protein synthesis.
To further characterize IL-4 effects upon metalloproteinase production, a dose titration experiment was performed. Human alveolar macrophages were exposed to various concentrations of IL-4 for 72 h and secretion of 92-kD type IV collagenase and TIMP were quantified by ELISA on the same samples of conditioned medium. As shown in Fig. 1 , spontaneous re- Table III, collagenase secretion was stimulated to readily measureable levels by the addition of k.S.aureus to cell cultures ( 10 bacteria/cell). Similarly, production of92-kD enzyme and ofTIMP were increased substantially from basal levels. IL-4 ( 10 ng/ml) reduced spontaneous production of 92-kD enzyme by -50%. After stimulation with killed bacteria, interstitial collagenase secretion was decreased 90% by IL-4, whereas 92-kD enzyme release was inhibited > 50%. Thus, IL-4 is capable of reducing both basal and stimulated metalloproteinase production with nearly equal efficacy. Upon simultaneous analysis of conditioned media samples, TIMP biosynthesis was unaffected by IL-4. A dose titration was also performed to further characterize IL-4 inhibition of stimulated macrophage metalloproteinase production (Fig. 2) . Increasing concentrations of IL-4 were added to k. S. aureus-stimulated macrophages and the conditioned media simultaneously assayed for interstitial collagenase and 92-kD type IV collagenase. As shown in Fig. 2 , suppression of each metalloenzyme by IL-4 was parallel and very nearly identical. 50% inhibition of the release of each proteinase was observed at 0.1-0.5 ng/ml of IL-4.
To gain insights into the intracellular processes responsible for IL-4 inhibition of metalloproteinase production, metabolic labeling and immunoprecipitation experiments were performed. Human alveolar macrophages were cultured in the presence of LPS to stimulate interstitial collagenase and TIMP biosynthesis. The LPS-stimulated cells were then exposed to 35S-methionine in the presence or absence of IL-4 and the newly synthesized labeled proteins immunoprecipitated with specific antisera to interstitial collagenase and TIMP. As shown in Fig. 3 , IL-4 reduced LPS-stimulated interstitial collagenase biosynthesis in a manner completely analogous to its effects upon steady state protein levels shown in Fig. 2 . In contrast, LPS-stimulated biosynthesis of TIMP was entirely unaffected, even at the highest tested concentration of the cytokine. These data demonstrate that IL-4 exerts its action at the level of new protein synthesis. Furthermore, IL-4 is capable of inhibiting metalloproteinase biosynthesis even after macrophage stimulation by different ligands (soluble endotoxin or the ingestion of k. S.aureus).
To further assess mechanism of regulatory control exerted by IL-4, we examined steady state mRNA levels by Northern hybridization. Total RNA was isolated as described in Methods, resolved by formaldehyde-agarose electrophoresis, and hybridized to 92-kD type IV collagenase cDNA ( 12) . As shown in Fig. 4 4(10ng/ml),IL-6(2 ng/ml), IFN-gamma (500 U/ml), or IL-2 (I ng/ml). Total RNA was harvested and subjected to Northern analysis using a cDNA probe for 92-kD type IV collagenase ( 12 (26, 27) . To evaluate the effects of the simultaneous presence ofboth cytokines upon macrophage metalloproteinase production, cells were incubated with IL-4 in the presence of increasing concentrations of IFN-,y. As shown in Fig. 5 A, IFN-' y suppressed production of92-kD collagenase, consistent with its previously reported capacity to inhibit metalloproteinase secretion (5). IL-4 alone also decreased 92-kD enzyme synthesis as discussed above. When both cytokines were present together, production of the 92-kD enzyme was inhibited by > 75%, an amount much larger than each agent caused alone in this experiment. Despite such cooperativity, we failed to detect synergism between IFN-y and IL-4. Low concentrations of either agent were not potentiated by the simultaneous presence of small amounts of the other (not shown).
Since production of cytokines is highly relevant to the inflammatory response, we determined amounts of IL-l1a and TNFa secreted by the same cultures of macrophages that had been treated with IL-4 in the presence ofincreasing amounts of IFN-gamma as described above. Consistent with previous reports (23, 24) , IL-4 caused suppression of macrophage release of IL-la and TNFa, whereas IFN-,y potently stimulated secretion ofthese cytokines (Figs. 5, B and C) . As also shown in Fig.  5 , IL-4 clearly antagonized the cytokine stimulation induced by IFN-y. These data indicate that IL-4 and IFN-,y oppose each other's actions in modulating macrophage cytokine production, whereas they function coordinately to suppress the biosynthesis of metalloproteinases. Therefore, although secreted proteinases and cytokines (via their actions on fibroblasts [ 3, 4] ) represent important components of the macrophage's arsenal to direct matrix degradation, their expression appears to be regulated quite differently.
To gain insights into the role ofcell differentiation upon the capacity of IL-4 to suppress mononuclear phagocyte metalloproteinase production, we examined the effects ofthis cytokine upon 92-kD enzyme release by freshly harvested human blood monocytes. As shown in Table IV , IL-4 caused a dose-dependent and significant reduction in the spontaneous secretion of (22) . However, IL-4 also decreases FcyRI-II-III expression, inhibits the monocyte's production of IL-1, TNFa, and IL-6 (23, 24) , and most recently has been shown to block osteoclast formation from progenitor mononuclear cells (25) . The data presented in this manuscript demonstrate that IL-4 can potently suppress the macrophage's capacity to produce its two principal metalloproteinases, 92-kD type IV collagenase and interstitial collagenase, without affecting the simultaneous release of the counter-regulatory inhibitor TIMP. Metalloproteinase biosynthesis was blocked by IL-4 both constitutively and also in cells stimulated by the ingestion ofk. S.aureus or by exposure to endotoxin. Although our specific antisera and cDNA probes do not distinguish between activated and zymogen enzyme forms, it is very likely that diminished metalloproteinase activity also results from IL-4 exposure. The inability of IL-4 to modulate TIMP levels provides yet another example, along with retinoids (36), IFN-'y (5) , and IL-6 (37), of the potential for dissociated regulation of secreted metalloproteinases versus TIMP.
We have previously reported (5) that IFN-gamma, another cytokine released by activated T lymphocytes that is capable of influencing macrophage function, inhibits the latter cells' capacity for metalloproteinase production. Interstitial collagenase and stromelysin biosynthesis were exquisitely sensitive to this agent (10 U/ml caused 50% inhibition; [5] ), whereas 92-kD enzyme production was affected at higher cytokine concentrations (> 50 U/ml). This result was quite unexpected since IFN--y is a potent upregulator ofvirtually all other macrophage biological functions, including stimulation ofclass II MHC antigen and FcyR expression, antigen presenting capacity, ADCC activity, antibody-dependent cellular cytotoxicity, tumoricidal and microbicidal activity, oxidative metabolism, and the production of monokines (6, 7, 26, 27) . Interestingly, for all ofthese activities except class II MHC antigen expression and antigen-presenting capacity, IL-4 specifically antagonizes the action of IFN-gamma (26, 27) . In this regard, our findings of IL-4 potentiation of IFN--y's ability to inhibit macrophage metalloproteinase production may be of considerable biological importance. Although the actions of both lymphokines appear to be additive rather than synergistic, it is clear that potent suppression of enzyme biosynthesis results from their combined presence (Fig. 5) .
Another cytokine secreted by T lymphocytes, IL-6, has been reported to specifically stimulate TIMP production in fibroblasts without measureable effect upon metalloproteinases (37) . The data in the present study examining a different cell type, the human alveolar macrophage, confirm these actions. IL-6 stimulated TIMP biosynthesis by twofold; production of interstitial collagenase and 92-kD type IV collagenase were only inconsistently affected (Table I) . In fact, when IL-6 and IL-4 were present simultaneously in culture medium, each cytokine appeared to function independently ofthe other; IL-6 specifically augmented TIMP production whereas IL-4 blocked the release of metalloproteinases (data not shown).
Mononuclear phagocytes have the capacity to mediate matrix degradation by two distinct biological strategies, the elaboration of cytokines such as IL-1 and TNFa, which stimulate fibroblast production of metalloproteinases, and also by secretion of their own battery of enzymes. The data presented here strongly suggest that control mechanisms for each of these pathways are separate and dissociated. IL-4 suppresses macrophage secretion of IL-lI3, IL-la, and TNFa (23, 24) , results which we have confirmed in this study. Similarly, this lymphokine inhibits the macrophage's own expression of matrix metalloproteinases. However, IFN--y potently enhances macrophage production of the above cytokines (6, 7) while ablating the cells' capacity for degradative enzyme release (5) . Indeed, we have shown that although IL-4 antagonizes IFN-y-mediated stimulation of macrophage cytokine production, it potentiates the latter's suppression of macrophage metalloproteinases (Fig. 5) . In this regard, it is of interest that emerging data suggest the existence ofdifferent subpopulations ofT lymphocytes that preferentially express either IFN-y or IL-4 (38).
Such cell subsets could conceivably modulate monocyte-macrophage production ofmetalloproteinases and cytokines differentially. In any event, although macrophages can exert control over matrix degradation via directing the production of fibroblast-stimulating cytokines and also by the elaboration oftheir own metalloproteinases, cellular mechanisms controlling these pathways appear to be different.
The data presented in this report strongly suggest that soluble factors released by activated T lymphocytes function coordinately to suppress the macrophage's capacity to synthesize metalloproteinases and thereby to promote extracellular matrix degradation. IL-4 and IFN-gamma block the biosynthesis of interstitial collagenase and 92-kD type IV collagenase without altering TIMP production. IL-6 stimulates the synthesis of TIMP in the absence of consistent effect upon the metalloproteinases. Other T cell cytokines appear to lack significant capacity to modulate macrophage expression of enzymes or inhibitors. In this regard, it is interesting that we have recently described the marked induction of mononuclear phagocyte cytokine (IL-1, TNFa) release by a mechanism involving cell surface contact between activated T lymphocytes and monocytes (Vey, E., J.-H. Zhang, and J.-M. Dayer, manuscript submitted for publication). If such cell-cell contact were to also stimulate metalloproteinase expression, a biological strategy might exist whereby T cells suppress macrophage degradative capacity by the release of soluble factors and enhance it via direct cell surface interaction. Studies to address this possibility are currently in progress.
